Fecal incontinence is more common than people think. 1 in 15 people live with fecal incontinence in Europe.²
Fecal Incontinence
Towards freedom
Talk to your patients about a life that isn’t ruled by fecal incontinence.
If you have patients who have already tried conservative therapies to overcome their fecal incontinence, talk to them about InterStim™ therapy – it could be the solution they’ve been looking for.
It's time to talk.
Fecal incontinence can be an awkward topic for doctors and patients.
It’s common for patients to find fecal incontinence difficult to discuss. It could explain why so many people living with fecal incontinence remain undiagnosed. Being able to talk about a condition is an important step in the process of resolving the problem.
Sphincteroplasty.
Still the best treatment for
Fecal Incontinence?
Not always….
Sign up to access the webinar recordings from Mr. Suchil Maslekar, St. James University Hospital, if you would like to learn more about the Surgical management options for Fecal Incontinence.
A common problem
- HCP related
- Patient related
More powerful
Much more than a programmer...
InterStim™ smart programmer.
Innovation at your fingertips
InterStim™
SureScan™
SureScan™ technology helps ensure patient safety and technician
convenience for MRI scans.
Sacral Neuromodulation Product portfolio
View the list products within our portfolio
InterStim™
Next generation neurostimulator
Procedure
checklist
Clinician technical guide
Your bladder control matters
Your bowel control matters
Choose a suitable solution for your patients
View the patient information guide
Could Sacral Neuromodulation therapy be right for your patients?
Many patients with chronic fecal incontinence are considered suitable for the InterStim™ systems if they have failed with (or are not candidates for) more conservative treatments such as medication, behavior modifcations, bowel retraining, and/or pelvic muscle training.
Treatment with InterStim™ systems is most appropriate for fecal incontinence patients who:
- have frequent bowel accidents
- experience urge incontinence and/or passive incontinence
- need another option in addition to physiotherapy and biofeedback
How can InterStim™ therapy help
control fecal incontinence?
Often, fecal incontinence is the result of impaired communication between the brain and the bowel.
Once implanted (usually by a colorectal surgeon), the InterStim™ system electrically stimulates the sacral nerve plexus. This is thought to normalize neural communication between the bladder and brain and between the bowel and brain.6,7
The InterStim™ system is an established therapy that has been used for more than 25 years and by more than 375,000 people worldwide.*
Find out more about InterStim™ therapy
Your patients could trial InterStim™ therapy
If it’s agreed that InterStim™ therapy would be a good option for your patients, they will have opportunity to evaluate it for between 7 to 28 days depending on the type of trial chosen.†
InterStim™
therapy is changing people's
lives
After 1 year of
using InterStim™
After 5 years of
using InterStim™
After 1 year of
using InterStim™
After 5 years of
using InterStim™
- Container
PHYSICIAN TESTIMONIAL
Sacral
Neuromodulation
therapy "...an absolute game-changer..."
"SNM has been an absolute game-
changer in the treatment of incontinence.
To be able to achieve truly life-altering improvements with such a minimal invasive procedure still exhilarates me."
Miss Kim Gorissen
Consultant in Emergency & Colorectal Surgery
Oxford University Hospitals NHS Foundation Trust.
Footnotes
* 375,000 - InterStim™ Implant Numbers, version 1.0, August-2022.
† Basic Evaluation is up to 7 days and the Advanced Evaluation is up to 28 days.
‡ Clinical success dened as ≥ 50% reduction in episodes/week.
References
- Damon, H. et al. Prevalence of anal incontinence in adults and impact on quality-of-life. Gastroenterol. Clin. Biol. 30, 37–43 (2006).
- Giebel, G. D., Lefering, R., Troidl, H. & Blöchl, H. Prevalence of fecal incontinence: what can be expected? Int. J. Colorectal Dis.13, 73–7 (1998).
- Eurostat Data Explorer for EU28: https://ec.europa.eu/eurostat/data/database.
- Niu et al. Neurologia volume 32, issue 8, pp. 523-532 (2017).
- Selroos et al. European Respiratory Review 24:474-483 (2015).
- Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. Urol Clin North Am. 2005;32:11–18.
- Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100:959–968.
- Wexner SD, Coller JA, Devroede G, et al. Sacral nerve stimulation for fecal incontinence: results of a 120-patient prospective multicenter study. Ann Surg. 2010 Mar;251(3):441-449.
- Hull T, Giese C, Wexner SD, Mellgren A, Devroede G, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013;56:234–245.
The patient testimonial relates an account of an individual’s response to the treatment. The account is genuine, typical and documented. However, the individual’s response does not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. The response other persons have to the treatment could be different. Responses to the treatment discussed can and do vary and are specific to the individual patient. Please consult your healthcare professional for a full list of benefits, indications, precautions, clinical results, and other important medical information that pertains to the therapy or products discussed.
The information contained on the website is designed to help you learn more about the therapy. It is intended to provide you with helpful information but is for information purposes only, is not medical advice and should not be used as an alternative to speaking with your doctor. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information, please speak to your healthcare professional.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events.
If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on: https://manuals.medtronic.com/manuals/main/region or https://www.medtronic.com/manuals.
Manuals can be viewed using a current version of any major internet browser.
For best results, use Adobe Acrobat® Reader with the browser.